Bank of America’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2
| Closed | – | – | 8506 |
|
|
2025
Q1 | $0 | Buy |
2
+1
| +100% | +$10 | ﹤0.01% | 8399 |
|
|
2024
Q4 | $26 | Hold |
1
| – | – | ﹤0.01% | 7981 |
|
|
2024
Q3 | $32 | Hold |
1
| – | – | ﹤0.01% | 7895 |
|
|
2024
Q2 | $47 | Buy |
+1
| New | +$74 | ﹤0.01% | 7853 |
|
|
2024
Q1 | – | Sell |
-2
| Closed | -$230 | – | 7631 |
|
|
2023
Q4 | $369 | Buy |
+2
| New | +$378 | ﹤0.01% | 7313 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7662 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7560 |
|
|
2023
Q1 | – | Hold |
0
| – | -$54 | – | 7996 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7781 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7996 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8160 |
|
|
2022
Q1 | – | Sell |
-31
| Closed | -$34.3K | – | 8454 |
|
|
2021
Q4 | $35K | Sell |
31
-1
| -3% | -$1.37K | ﹤0.01% | 7350 |
|
|
2021
Q3 | $49K | Buy |
32
+31
| +3,100% | +$49.6K | ﹤0.01% | 7055 |
|
|
2021
Q2 | $2K | Sell |
1
-123
| -99% | -$225K | ﹤0.01% | 7542 |
|
|
2021
Q1 | $228K | Buy |
+124
| New | +$272K | ﹤0.01% | 5940 |
|
|
2020
Q4 | – | Sell |
-33
| Closed | -$85.5K | – | 7189 |
|
|
2020
Q3 | $103K | Buy |
+33
| New | +$118K | ﹤0.01% | 5693 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6940 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6998 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7209 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7343 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7272 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7223 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7204 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7341 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7174 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7192 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7111 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7138 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 7029 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 7077 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 7144 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6929 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 7210 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 7121 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7355 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 7041 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 7125 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 7263 |
|
Other funds holding HEPA
Bank of America's HEPA Position: Q2 2025 in Review
Bank of America sold out of Hepion Pharmaceuticals (HEPA) in Q2 2025, closing a stake of 2 shares.
Bank of America first reported a position in HEPA in Q3 2020 and held it in 10 quarters. The position peaked at $228K in Q1 2021. 4 funds tracked by Wall St. Rank hold HEPA as of Q2 2025.
- Bank of America reported no remaining Hepion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Bank of America sold 2 Hepion Pharmaceuticals shares in Q2 2025.
- Bank of America first reported a position in Hepion Pharmaceuticals in Q3 2020 and held it in 10 quarters.
- Bank of America's Hepion Pharmaceuticals position peaked at $228K in Q1 2021.
- 4 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2025.
Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.